Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Germano Perotti

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Clinical Nuclear Medicine|March 1, 2013
Pulmonary neuroendocrine tumor incidentally detected by (18)F-CH PET/CTGiorgio Treglia, Filippo Lococo, Gianluigi Petrone, et al.
Nuclear Medicine Communications|July 4, 2013
Determining the appropriate time of execution of an I-131 post-therapy whole-body scan: comparison between early and late imagingMassimo Salvatori, Germano Perotti, Maria F Villani, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literatureGiorgio Treglia, Paola Castaldi, Maria Felicia Villani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2017
Evaluation of Dual-Timepoint <sup>18</sup>F-FDG PET/CT Imaging for Lymph Node Staging in Vulvar CancerAngela Collarino, Giorgia Garganese, Renato A Valdés Olmos, et al.
The American Journal of Gastroenterology|October 22, 2009
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?Emidio Scarpellini, Venanzio Valenza, Maurizio Gabrielli, et al.
Annals of Surgical Oncology|May 3, 2024
Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid CarcinomasLuca Sessa, Carmela De Crea, Nikolaos Voloudakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2012
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinomaGiorgio Treglia, Paola Castaldi, Maria Felicia Villani, et al.
Pituitary|December 31, 2011
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control studyAlessandra Fusco, Antonella Giampietro, Antonio Bianchi, et al.
Clinical Nuclear Medicine|January 22, 2015
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoidFilippo Lococo, Germano Perotti, Giuseppe Cardillo, et al.
Targeted Oncology|November 29, 2024
Defining the Position of [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical TrialsChiara Ciccarese, Matteo Bauckneht, Luca Zagaria, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical Nuclear Medicine|March 1, 2013
Pulmonary neuroendocrine tumor incidentally detected by (18)F-CH PET/CTGiorgio Treglia, Filippo Lococo, Gianluigi Petrone, et al.
Nuclear Medicine Communications|July 4, 2013
Determining the appropriate time of execution of an I-131 post-therapy whole-body scan: comparison between early and late imagingMassimo Salvatori, Germano Perotti, Maria F Villani, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literatureGiorgio Treglia, Paola Castaldi, Maria Felicia Villani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2017
Evaluation of Dual-Timepoint <sup>18</sup>F-FDG PET/CT Imaging for Lymph Node Staging in Vulvar CancerAngela Collarino, Giorgia Garganese, Renato A Valdés Olmos, et al.
The American Journal of Gastroenterology|October 22, 2009
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?Emidio Scarpellini, Venanzio Valenza, Maurizio Gabrielli, et al.
Annals of Surgical Oncology|May 3, 2024
Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid CarcinomasLuca Sessa, Carmela De Crea, Nikolaos Voloudakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2012
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinomaGiorgio Treglia, Paola Castaldi, Maria Felicia Villani, et al.
Pituitary|December 31, 2011
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control studyAlessandra Fusco, Antonella Giampietro, Antonio Bianchi, et al.
Clinical Nuclear Medicine|January 22, 2015
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoidFilippo Lococo, Germano Perotti, Giuseppe Cardillo, et al.
Targeted Oncology|November 29, 2024
Defining the Position of [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical TrialsChiara Ciccarese, Matteo Bauckneht, Luca Zagaria, et al.
Pageof 4